Skip to content
Search

Latest Stories

Mark Wood exploring slow ball variations for T20 World Cup

Mark Wood exploring slow ball variations for T20 World Cup

MARK Wood got the ability to surprise batsmen with his pace but with the World Twenty20 seven months away the England pacer is make an effort to add variations to his bowling.

Currently, playing a key role in England's campaign in the T20I series against India, Wood realises the importance of having a slower ball in his arsenal in Indian conditions ahead of the T20 World Cup.


When playing alongside Shardul Thakur At Chennai Super Kings, made him realise that a slow yorker and a slow ball can be valuable assets for any bowler in limited-overs cricket.

"Watching their bowlers... I played with Shradul Thakur at Chennai (Super Kings). And he's got a new slower ball. So just looking at that and how well that's worked here, it's something that I'm trying to adapt into my game," Wood told during a media interaction on Wednesday (17).

"My role has been pretty clear, the plans that I have been trying to do. Behind the scenes, I'm still trying to learn new things, slow balls try to get that on my yorker ball and so there are always things to improve on.

"These are the conditions we're gonna come up against in the World Cup, so it's trying to get the right skills in place to be able to adapt on any given surface or the type of pitches we might come across here," he explained.

Wood has so far done well in the ongoing T20 series and hopes his performances will help him book a place in the squad for the upcoming T20 World Cup.

"It gives me a chance to prove myself in this series and ultimately we all want to be part of that group that plays in the World Cup and hopefully wins the World Cup for England.

"We've got plenty of backups, people go in and out of form, and injuries will come and go. So it's important that, as a group, no one takes a sport for granted." Wood said.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less